On ECHEMI
Home > Drugs > Beijing SL Pharmaceutical Co., Ltd.
Beijing SL Pharmaceutical Co., Ltd.
  • Founded in:

    1994-12-24
  • Country:

    China China
  • Address:

    4th Floor, Building 1, Bitongyuan, No. 69, Fushi Road, Haidian District, Beijing
  • Tax NO.:

    91110000102299779W
  • Registered Funds:

    1,027.35 million yuan
  • Website:

  • Email:

Related Drugs
Octreotide acetate
Octreotide acetate
Name Description Content CAS NO. Registered Holders
Octreotide acetate

83150-76-9 45
Ribavirin Tablets
Ribavirin
Name Description Content CAS NO. Registered Holders
Ribavirin

Broad-spectrum antiviral drug. It has the effect of inhibiting the growth of multiple viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. in vitro, and its mechanism is not fully understood. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.

More

Broad-spectrum antiviral drug. It has the effect of inhibiting the growth of multiple viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. in vitro, and its mechanism is not fully understood. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.

36791-04-5 33
Valacyclovir Hydrochloride
Name Description Content CAS NO. Registered Holders
Valacyclovir Hcl

Unspecified

More

Unspecified

136489-37-7 138
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.